Mark Toshner

Latest

• Enhancing patient outcomes and statistical efficiency in rare-disease phase-II trials. The StratosPHere 2 study (Invited Talk @ Italian Bayesian Day 2023)
• Enhancing patient outcomes and statistical efficiency in rare-disease phase-II trials. The StratosPHere 2 study (Poster @ ISCB2023 - Joint conference with the IBS)